222 related articles for article (PubMed ID: 29906708)
1. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
Nisha Y; Bobby Z; Wadwekar V
Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
[TBL] [Abstract][Full Text] [Related]
2. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
Sidhu HS; Srinivas R; Sadhotra A
Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
[TBL] [Abstract][Full Text] [Related]
3. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
[TBL] [Abstract][Full Text] [Related]
4. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.
Luef G; Abraham I; Hoppichler F; Trinka E; Unterberger I; Bauer G; Lechleitner M
Metabolism; 2002 Oct; 51(10):1274-8. PubMed ID: 12370846
[TBL] [Abstract][Full Text] [Related]
5. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
[TBL] [Abstract][Full Text] [Related]
6. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
Pylvänen V; Pakarinen A; Knip M; Isojärvi J
Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
[TBL] [Abstract][Full Text] [Related]
7. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and endocrine effects of valproic acid chronic treatment.
Belcastro V; D'Egidio C; Striano P; Verrotti A
Epilepsy Res; 2013 Nov; 107(1-2):1-8. PubMed ID: 24076030
[TBL] [Abstract][Full Text] [Related]
9. Valproic Acid related metabolic syndrome in patients with epilepsy.
Mania M; Kasradze S; Okujava N
Georgian Med News; 2011 May; (194):43-7. PubMed ID: 21685521
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia.
Rakitin A; Eglit T; Kõks S; Lember M; Haldre S
PLoS One; 2014; 9(7):e103856. PubMed ID: 25078464
[TBL] [Abstract][Full Text] [Related]
11. Fasting insulin and HOMA-index changes in patients treated with valproic acid.
Mania M; Javashvili L; Kasradze S; Okujava N
Georgian Med News; 2011 Oct; (199):48-52. PubMed ID: 22155806
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in patients on valproic acid: relation to adiponectin.
Aly RH; Amr NH; Saad WE; Megahed AA
Acta Neurol Scand; 2015 Mar; 131(3):169-75. PubMed ID: 25286962
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidative stress in epileptic children treated with valproic acid.
Verrotti A; Scardapane A; Franzoni E; Manco R; Chiarelli F
Epilepsy Res; 2008 Feb; 78(2-3):171-7. PubMed ID: 18164182
[TBL] [Abstract][Full Text] [Related]
14. Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid.
Ozdemir O; Yakut A; Dinleyici EC; Aydogdu SD; Yarar C; Colak O
Eur J Pediatr; 2011 Jul; 170(7):873-7. PubMed ID: 21140275
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of adiponectin and leptin levels and oxidative stress in bipolar disorder patients with metabolic syndrome treated by valproic acid.
Akgün S; Köken T; Kahraman A
J Psychopharmacol; 2017 Nov; 31(11):1453-1459. PubMed ID: 28875764
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
Kim JY; Lee HW
Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
[TBL] [Abstract][Full Text] [Related]
17. Fasting serum insulin and lipid levels in men with epilepsy.
Pylvänen V; Knip M; Pakarinen AJ; Turkka J; Kotila M; Rättyä J; Myllylä VV; Isojärvi JI
Neurology; 2003 Feb; 60(4):571-4. PubMed ID: 12601094
[TBL] [Abstract][Full Text] [Related]
18. Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate.
Tokgoz H; Aydin K; Oran B; Kiyici A
Childs Nerv Syst; 2012 Jul; 28(7):1049-53. PubMed ID: 22645062
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy.
Söylemez E; Öztürk O; Baslo SA; Balçık ZE; Ataklı D
Epilepsy Behav; 2020 Oct; 111():107296. PubMed ID: 32769040
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.
Rakitin A; Kõks S; Haldre S
Seizure; 2016 May; 38():11-6. PubMed ID: 27061880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
